Terms: = Brain cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1 AND Prognosis
1 results:
1. Combined elevation of TRIB2 and map3k1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.
Wang J; Zuo J; Wahafu A; Wang MD; Li RC; Xie WF
CNS Neurosci Ther; 2020 Mar; 26(3):297-308. PubMed ID: 31318172
[TBL] [Abstract] [Full Text] [Related]
